HSBC Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $656K | Sell |
72,463
-17,944
| -20% | -$162K | ﹤0.01% | 1578 |
|
|
2025
Q1 | $677K | Buy |
90,407
+346
| +0.4% | +$2.59K | ﹤0.01% | 1512 |
|
|
2024
Q4 | $677K | Buy |
90,061
+22,814
| +34% | +$171K | ﹤0.01% | 1630 |
|
|
2024
Q3 | $529K | Sell |
67,247
-57,757
| -46% | -$454K | ﹤0.01% | 1624 |
|
|
2024
Q2 | $759K | Buy |
125,004
+30,788
| +33% | +$187K | ﹤0.01% | 1466 |
|
|
2024
Q1 | $479K | Buy |
94,216
+73,181
| +348% | +$372K | ﹤0.01% | 1746 |
|
|
2023
Q4 | $127K | Buy |
21,035
+2,160
| +11% | +$13K | ﹤0.01% | 2090 |
|
|
2023
Q3 | $134K | Buy |
+18,875
| New | +$134K | ﹤0.01% | 2005 |
|
|
2021
Q3 | – | Sell |
-15,463
| Closed | -$246K | – | 2498 |
|
|
2021
Q2 | $246K | Buy |
+15,463
| New | +$246K | ﹤0.01% | 2219 |
|
|
2021
Q1 | – | Sell |
-34,869
| Closed | -$260K | – | 2336 |
|
|
2020
Q4 | $260K | Sell |
34,869
-12,059
| -26% | -$89.9K | ﹤0.01% | 2228 |
|
|
2020
Q3 | $164K | Sell |
46,928
-84,844
| -64% | -$297K | ﹤0.01% | 2085 |
|
|
2020
Q2 | $628K | Sell |
131,772
-61,393
| -32% | -$293K | ﹤0.01% | 1353 |
|
|
2020
Q1 | $382K | Buy |
193,165
+182,192
| +1,660% | +$360K | ﹤0.01% | 1526 |
|
|
2019
Q4 | $38K | Buy |
+10,973
| New | +$38K | ﹤0.01% | 2420 |
|
|
2017
Q1 | – | Sell |
-12,654
| Closed | -$80K | – | 1724 |
|
|
2016
Q4 | $80K | Buy |
+12,654
| New | +$80K | ﹤0.01% | 2190 |
|